Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

Holbrook E. Kohrt, A. Dimitrios Colevas, Roch Houot, Kipp Weiskopf, Matthew J. Goldstein, Peder Lund, Antonia Mueller, Idit Sagiv-Barfi, Aurelien Marabelle, Ruth Lira, Emily Troutner, Lori Richards, Amanda Rajapaska, Jonathan Hebb, Cariad Chester, Erin Waller, Anton Ostashko, Wen Kai Weng, Lieping Chen, Debra CzerwinskiYang Xin Fu, John Sunwoo, Ronald Levy

    Résultats de recherche: Contribution à un journal!!Comment/debate

    4 Citations (Scopus)

    Résumé

    Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

    langue originaleAnglais
    Pages (de - à)2595
    Nombre de pages1
    journalJournal of Clinical Investigation
    Volume129
    Numéro de publication6
    Les DOIs
    étatPublié - 3 juin 2019

    Contient cette citation